Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 14/20 | 0.68 |
| ▸ | ADRB1 | P08588 | 12/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6539492 | 0.91 | ADRB3 (0.73) | ADRB3ADRB1MAPT | |
| Trifluoroacetic Acid SCHEMBL6538830 | 0.89 | ADRB3 (0.76) | ADRB3ADRB1MAPT | |
| SCHEMBL6538734 | 0.89 | ADRB3 (0.54) | ADRB3ADRB1CA12CA1CA2 | |
| SCHEMBL6539324 | 0.87 | ADRB3 (0.80) | ADRB3ADRB1MAPT | |
| Trifluoroacetic Acid SCHEMBL6539730 | 0.86 | ADRB3 (0.75) | ADRB3ADRB1MAPT | |
| Trifluoroacetic Acid SCHEMBL6539378 | 0.86 | ADRB3 (0.76) | ADRB3ADRB1MAPTSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL6539409 | 0.85 | ADRB3 (0.75) | ADRB3ADRB1MAPTALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL6539886 | 0.85 | ADRB3 (0.75) | ADRB3ADRB1MAPTMAPK1TDP1 | |
| Trifluoroacetic Acid SCHEMBL6538892 | 0.84 | ADRB3 (0.79) | ADRB3ADRB1MAPT | |
| Trifluoroacetic Acid SCHEMBL6538789 | 0.84 | ADRB3 (0.70) | ADRB3ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6826033-B2 | BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20040037022-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-02-26 | — | — | US | disclosed |